mTOR pp 295-303

Part of the Methods in Molecular Biology book series (MIMB, volume 821)

Rapamycin-Induced Enhancement of Vaccine Efficacy in Mice

Protocol

Abstract

Th1 immunity protects against tuberculosis infection in mice and humans. The widely used BCG vaccine primes CD4 and CD8 T cells through signaling mechanisms from dendritic cells and macrophages. The latter express MHC-II and MHC-I molecules through which peptides from BCG vaccine are presented to CD4 and CD8 T cells, respectively. Since BCG sequesters within a phagosome that does not fuse with lysosomes, generation of peptides within antigen-presenting cells infected with BCG occurs with reduced efficiency. We demonstrate that activation of DCs containing BCG vaccine with rapamycin leads to an enhanced ability of DC vaccines to immunize mice against tuberculosis. Coadministration of rapamycin with BCG vaccine also enhanced Th1 immunity. We propose that rapamycin-mediated increase in Th1 responses offers novel models to study mTOR-mediated regulation of immunity.

Key words

Rapamycin Mycobacterium tuberculosis BCG vaccine Mouse mTOR CD4 CD8 T cells Th1 immunity 

References

  1. 1.
    Luo, H., W. Duguid, H. Chen, M. Maheu, and J. Wu. 1994. The effect of rapamycin on T cell development in mice. Eur J Immunol 24:692–701.PubMedCrossRefGoogle Scholar
  2. 2.
    Anderson, K. M., and J. C. Zimring. 2006. Rapamycin prolongs susceptibility of responding T cells to tolerance induction by CD8+ veto cells. Transplantation 81:88–94.PubMedCrossRefGoogle Scholar
  3. 3.
    Araki, K., A. P. Turner, V. O. Shaffer, S. Gangappa, S. A. Keller, M. F. Bachmann, C. P. Larsen, and R. Ahmed. 2009. mTOR regulates memory CD8 T-cell differentiation. Nature 460:108–112.PubMedCrossRefGoogle Scholar
  4. 4.
    Ferrer, I. R., M. E. Wagener, J. M. Robertson, A. P. Turner, K. Araki, R. Ahmed, A. D. Kirk, C. P. Larsen, and M. L. Ford. Cutting edge: Rapamycin augments pathogen-specific but not graft-reactive CD8+ T cell responses. J Immunol 185:2004–2008.Google Scholar
  5. 5.
    Saemann, M. D., M. Haidinger, M. Hecking, W. H. Horl, and T. Weichhart. 2009. The multifunctional role of mTOR in innate immunity: implications for transplant immunity. Am J Transplant 9:2655–2661.PubMedCrossRefGoogle Scholar
  6. 6.
    Jagannath, C., D. R. Lindsey, S. Dhandayuthapani, Y. Xu, R. L. Hunter, Jr., and N. T. Eissa. 2009. Autophagy enhances the efficacy of BCG vaccine by increasing peptide presentation in mouse dendritic cells. Nat Med 15:267–276.PubMedCrossRefGoogle Scholar
  7. 7.
    Clemens, D. L., and M. A. Horwitz. 1996. The Mycobacterium tuberculosis phagosome interacts with early endosomes and is accessible to exogenously administered transferrin. J Exp Med 184:1349–1355.PubMedCrossRefGoogle Scholar
  8. 8.
    Deretic, V., and R. A. Fratti. 1999. Mycobacterium tuberculosis phagosome. Mol Microbiol 31:1603–1609.PubMedCrossRefGoogle Scholar
  9. 9.
    Russell, D. G. 2001. Mycobacterium tuberculosis: here today, and here tomorrow. Nat Rev Mol Cell Biol 2:569–577.PubMedCrossRefGoogle Scholar
  10. 10.
    Singh, C. R., R. A. Moulton, L. Y. Armitige, A. Bidani, M. Snuggs, S. Dhandayuthapani, R. L. Hunter, and C. Jagannath. 2006. Processing and presentation of a mycobacterial antigen 85B epitope by murine macrophages is dependent on the phagosomal acquisition of vacuolar proton ATPase and in situ activation of cathepsin D. J Immunol 177:3250–3259.PubMedGoogle Scholar
  11. 11.
    Soualhine, H., A. E. Deghmane, J. Sun, K. Mak, A. Talal, Y. Av-Gay, and Z. Hmama. 2007. Mycobacterium bovis bacillus Calmette-Guerin secreting active cathepsin S stimulates expression of mature MHC class II molecules and antigen presentation in human macrophages. J Immunol 179:5137–5145.PubMedGoogle Scholar
  12. 12.
    Rao, R. R., Q. Li, K. Odunsi, and P. A. Shrikant. The mTOR kinase determines effector versus memory CD8+ T cell fate by regulating the expression of transcription factors T-bet and Eomesodermin. Immunity 32:67–78.Google Scholar
  13. 13.
    Sathaliyawala, T., W. E. O’Gorman, M. Greter, M. Bogunovic, V. Konjufca, Z. E. Hou, G. P. Nolan, M. J. Miller, M. Merad, and B. Reizis. Mammalian target of rapamycin controls dendritic cell development downstream of Flt3 ligand signaling. Immunity 33:597–606.Google Scholar

Copyright information

© Springer Science+Business Media, LLC  2012

Authors and Affiliations

  1. 1.Department of Pathology and Laboratory MedicineUniversity of Texas Medical SchoolHoustonUSA

Personalised recommendations